Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY900014 vs insulin lispro as prandial insulin in combination with basal insulin for type 2 diabetes
CTR20190257Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin lispro in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Apr 2019; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20190257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190257.